{'fraction_non_alphanumeric': 0.02553191489361702, 'fraction_numerical': 0.0070921985815602835, 'mean_word_length': 6.204081632653061, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): What We Know and Don't Know


 Development of vaccines to fight COVID19has been a remarkable medical achievement. However, this global immunization effort has been complicated by arare vaccine-related outcome characterized by thrombocytopenia and thrombosisin association with platelet-activating anti-platelet factor 4 antibodies.In this Spotlight article, we will discuss the recently described complication of vaccine-induced immune thrombotic thrombocytopenia (VITT)occurring in response to certain COVID19 vaccines. Although information about this clinical condition is rapidly evolving, we will summarize our current understanding of VITT.
